Successful treatment of a congenital extra-truncal vascular malformation by orally administered propranolol

Journal of Dermatological Treatment

Volumn 26, Issue 1, 2015, Pages 59-62

  Pföhler, Claudia ^a   Janssen, Eva ^a   Buecker, Arno ^a   Vogt, Thomas ^a   Müller, Cornelia S L ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Propranolol; Treatment; Vascular malformation

Indexed keywords

PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; VASCULOTROPIN A;

ABSENCE OF SIDE EFFECTS; ADULT; ANGIOGRAPHY; ANGIOOSTEOHYPERTROPHY SYNDROME; ARTICLE; CASE REPORT; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL EXTRA TRUNCAL VASCULAR MALFORMATION; DRUG TOLERABILITY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROPERITONEUM; SIGMOID; TREATMENT DURATION; TREATMENT OUTCOME; ANTAGONISTS AND INHIBITORS; KLIPPEL-TRENAUNAY-WEBER SYNDROME; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; VASCULAR MALFORMATIONS;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; FEMALE; HUMANS; KLIPPEL-TRENAUNAY-WEBER SYNDROME; PROPRANOLOL; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR MALFORMATIONS;

EID: 84924301174     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2013.869301     Document Type: Article

References (19)

1. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51.
2. Albinana V, Recio-Poveda L, Zarrabeitia R, et al. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia. Thromb Haemost 2012;108:41-53.
3. D'Angelo G, Lee H, Weiner RI. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997;67:353-66.
4. Hoger PH. [Hemangioma. New aspects of pathogenesis, differential diagnosis and therapy]. Hautarzt 2012;63:112-20.
5. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002;38:298-304.
6. Klippel M, Trenaunay P. U naevus variqueux osteo-hypertrophique. Arch Gen Med 1900;185:614-72.
7. Redondo P, Aguado L, Martinez-Cuesta A. Diagnosis and management of extensive vascular malformations of the lower limb: Part II. Systemic repercussions [corrected], diagnosis, and treatment. J Am Acad Dermatol 2011;65:909-23; quiz 24
8. Redondo P, Aguado L, Martinez-Cuesta A. Diagnosis and management of extensive vascular malformations of the lower limb: Part I. Clinical diagnosis. J Am Acad Dermatol 2011;65:893-906; quiz 7-8
9. Samuel M, Spitz L. Klippel-Trenaunay syndrome: clinical features, complications and management in children. Br J Surg 1995;82:757-61.
10. Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003;73:1240-9.
11. Tian XL, Kadaba R, You SA, et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 2004;427:640-5.
12. Lee BB, Laredo J, Kim YW, Neville R. Congenital vascular malformations: general treatment principles. Phlebology 2007;22:258-63.
13. Akhurst RJ. Taking thalidomide out of rehab. Nat Med 2010;16:370-2.
14. Aaslid R, Lash SR, Bardy GH, et al. Dynamic pressure-flow velocity relationships in the human cerebral circulation. Stroke 2003;34:1645-9.
15. Brown C, Subramanian V, Wilcox CM, et al. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: An overview and systematic review of prospective observational studies. Dig Dis Sci 2010;55:2129-34.
16. Burrows PE, Mulliken JB, Fishman SJ, et al. Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child. J Craniofac Surg 2009;20:597-602.
17. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010;162:466-8.
18. Itinteang T, Brasch HD, Tan ST, Day DJ. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg 2011;64:759-65.
19. Greenberger S, Bischoff J. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. Cold Spring Harb Perspect Med 2011;1:a006460.